Up Front
Has the Nursing Shortage Come to an End?
The shortage of RNs in the United States is not a new problem; in fact—with the exception of a period of time in the mid-1980s and early 1990s—it dates back to the 1960s. Yet, in recent years, employers in some parts of the country have reported a decrease in the demand for RNs, and in 2009 more than 54,000 qualified nursing school applicants were denied admission to nursing schools. These findings have led many people to ask, has the nursing shortage come to an end? In a word, the answer is no.
Loading ...RE:Connect
A blog written by oncology nurses for oncology nurses
RE:Connect
Lessons From Leadership: Impressions From ELNEC-Core
Last week, I was fortunate enough to attend a train the trainer course presented by the End-of-Life Nursing Education Consortium (ELNEC) in beautiful Chicago, IL. The ELNEC-Core curriculum is designed to provide nurses with the tools and knowledge to disseminate much needed education regarding end-of-life care.Just In
Urine Test Could Detect Upper GI Cancers Sooner
Cancers of the gut, stomach, and pancreas could be detected sooner with a simple urine test, according to a new study.
ONS News
Nurse in Washington Internship Grants Are Available
The 2012 Nurse in Washington Internship (NIWI) program will be held in March at the Liaison Capitol Hill in Washington, DC. NIWI enables nurses to learn how to influence health care through the legislative and regulatory processes. Participants learn from health policy experts and government officials, network with other nurses, and visit members of Congress.
Just In
Screening Method Does Not Reduce Ovarian Cancer Mortality
New results from the National Cancer Institute–sponsored Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial show that screening for ovarian cancer with transvaginal ultrasound and the CA-125 blood test did not result in fewer deaths from the disease compared with usual care. In addition, false-positive results from the two screening methods often led to unnecessary surgeries and other serious complications.
Just In
High-Dose Methotrexate Improves Outcomes for B-Cell ALL
Children’s Oncology Group researchers have shown in a phase III clinical trial that radically increasing the dose of methotrexate used to treat patients with high-risk B-cell acute lymphoblastic leukemia significantly improves five-year survival when compared with the current standard of care.
ONS News
Long-Time “Voice of ONS” Retires
If you’ve called the ONS office’s main line, chances are you’ve spoken to ONS Receptionist Dee DelGreco. She has been the “voice of ONS” for nearly three decades, cheerfully greeting callers on behalf of ONS. After 24 years of service, DelGreco has announced her retirement.